Chong Kun Dang Pharmaceutical Corp. (185750) Stock Price & Analysis

185750 Stock Chart & Stats

$63,100.00$600.00(0.96%)

At close: Oct 30 3:30 PM GMT+9

Day’s Range: $62,000.00 - $64,700.00
52-Week Range: $61,000.00 - $98,100.00
Previous Close: $62,500.00
Volume: N/A
Average Volume (3M): 15.77K
Market Cap: KRW 831.41B
Enterprise Value: KRW 983.31B
Total Cash (Recent Filing): KRW 329.30B
Total Debt (Recent Filing): KRW 437.44B
Price to Earnings (P/E): 10.5
Beta: 0.12
Next Earnings: Nov 12, 2026 (Est.)
EPS Estimate: N/A
Last Dividend Ex-Date: Dec 29, 2025
Dividend Yield: 0.79%

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth

The substantial TTM revenue increase indicates strong demand or successful commercialization across the company’s pharmaceutical portfolio. If this expansion is sustained, it can broaden the revenue base, support pipeline investment, and improve operating scale over the next several quarters.

Solid Equity Base

A larger equity base than debt provides Chong Kun Dang with a meaningful financial foundation and reduces immediate balance-sheet stress. This supports continued research, development, manufacturing, and commercialization activity while offering some resilience if profitability remains pressured.

Improved Operating Cash Flow

The improvement in operating cash flow shows that the business is generating more cash from its operations than in the prior year. Although free cash flow remains negative, stronger operating inflows can help fund investment and reduce reliance on external financing if maintained.

Bears Say

Margin Compression

The sharp decline in gross and net margins reduces the quality of the company’s revenue growth and leaves less profit available from each unit of sales. Persistent compression could weaken reinvestment capacity and make earnings more sensitive to costs or product mix.

Negative Free Cash Flow

Repeatedly negative free cash flow indicates that investment and/or working-capital needs are exceeding internally generated cash after operations. If this persists, financial flexibility may narrow, potentially constraining pipeline development, expansion, or other capital allocation priorities.

Rising Leverage

The increase in debt relative to equity signals greater reliance on debt funding even though overall leverage remains moderate. Combined with weaker margins and negative free cash flow, further borrowing could increase financing pressure and reduce flexibility during an extended earnings slowdown.

Chong Kun Dang Pharmaceutical Corp. News

Chong Kun Dang Shows Profit Resilience Amid Mixed Q3 Sales

An announcement from Chong Kun Dang Pharmaceutical Corp. ( ($KR:185750) ) is now available. Chong Kun Dang Pharmaceutical reported provisional third-quarter 2026 sales of 430.7 billion KRW, down 9.4% from

2d ago

185750 FAQ

What was Chong Kun Dang Pharmaceutical Corp.’s price range in the past 12 months?

Chong Kun Dang Pharmaceutical Corp. lowest stock price was $61000.00 and its highest was $98100.00 in the past 12 months.

What is Chong Kun Dang Pharmaceutical Corp.’s market cap?

Chong Kun Dang Pharmaceutical Corp.’s market cap is ₩831.41B.

When is Chong Kun Dang Pharmaceutical Corp.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Chong Kun Dang Pharmaceutical Corp.’s earnings last quarter?

Chong Kun Dang Pharmaceutical Corp. released its earnings results on Aug 14, 2026. The company reported $1,517.376 earnings per share for the quarter.

Is Chong Kun Dang Pharmaceutical Corp. overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Chong Kun Dang Pharmaceutical Corp. pay dividends?

Chong Kun Dang Pharmaceutical Corp. pays a ― dividend of $500 which represents an annual dividend yield of 0.79%. See more information on Chong Kun Dang Pharmaceutical Corp. dividends here

What is Chong Kun Dang Pharmaceutical Corp.’s EPS estimate?

Chong Kun Dang Pharmaceutical Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Chong Kun Dang Pharmaceutical Corp. have?

Chong Kun Dang Pharmaceutical Corp. has 13,802,780 shares outstanding.

What happened to Chong Kun Dang Pharmaceutical Corp.’s price movement after its last earnings report?

Chong Kun Dang Pharmaceutical Corp. reported an EPS of $1,517.376 in its last earnings report. Following the earnings report the stock price went up 0.147%.

Which hedge fund is a major shareholder of Chong Kun Dang Pharmaceutical Corp.?

Currently, no hedge funds are holding shares in KR:185750

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description